IDH2 and astrocytoma (excluding glioblastoma): Wang et al. and Zhao et al., with a sample of 17 and 24 patients, respectively, also noted the diagnostic value of IDH mutations as a diagnostic liquid biopsy biomarker in astrocytoma patients, especially younger patients [38,45].